Bard Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.34M Sell
60,275
-9,695
-14% -$567K 0.37% 70
2025
Q2
$4.83M Sell
69,970
-11,795
-14% -$802K 0.58% 52
2025
Q1
$5.68M Sell
81,765
-3,625
-4% -$299K 0.69% 44
2024
Q4
$7.35M Sell
85,390
-3,500
-4% -$378K 0.88% 28
2024
Q3
$10.6M Sell
88,890
-8,275
-9% -$1.1M 1.25% 18
2024
Q2
$13.9M Buy
97,165
+2,260
+2% +$299K 1.43% 13
2024
Q1
$12.2M Sell
94,905
-2,475
-3% -$295K 1.29% 19
2023
Q4
$10.1M Buy
97,380
+2,670
+3% +$264K 1.13% 21
2023
Q3
$8.61M Sell
94,710
-3,600
-4% -$317K 1.06% 23
2023
Q2
$7.95M Sell
98,310
-3,300
-3% -$270K 0.6% 45
2023
Q1
$8.09M Sell
101,610
-3,000
-3% -$213K 0.65% 40
2022
Q4
$7.08M Sell
104,610
-1,750
-2% -$103K 0.6% 45
2022
Q3
$5.3M Buy
106,360
+500
+0.5% +$26.8K 0.5% 52
2022
Q2
$5.9M Sell
105,860
-250
-0.2% -$13.9K 0.54% 50
2022
Q1
$5.89M Sell
106,110
-1,000
-0.9% -$51.3K 0.48% 54
2021
Q4
$6M Sell
107,110
-400
-0.4% -$21.7K 0.48% 56
2021
Q3
$5.16M Sell
107,510
-200
-0.2% -$9.67K 0.46% 59
2021
Q2
$4.51M Sell
107,710
-1,250
-1% -$48.5K 0.4% 64
2021
Q1
$3.67M Sell
108,960
-11,000
-9% -$392K 0.36% 77
2020
Q4
$4.19M Buy
+119,960
New +$4.15M 0.42% 63

Other funds holding NVO